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Original Research Article  
Serum positivity of ANA and ASMA among khat and nonkhat 
chewers as markers for autoimmune hepatitis type 1 
Abstract 
Background: Autoimmune hepatitis (AIH) is a necroinflammatory liver disease of unknown 
etiology. It has been proposed that certain herbs such as black cohosh and dai-saiko might trigger 
AIH. Khat is an ever green tree whose leaves have been chewed by people in Yemen where AIH 
is common.  
Aims: To measure antinuclear antibodies (ANA) and anti-smooth muscle antibodies (ASMA) as 
serum markers for AIH type1 in healthy people who chew and do not chew khat. It also aimed to 
determine some other risk factors for ANA and ASMA positivity. 
Methods: A total of 100 healthy individuals were enrolled in this study. They were divided into: 
Daily khat chewers and non-khat chewers. Three ml peripheral blood was withdrawn from each 
participant. Blood samples were tested for ANA and ASMA using indirect immunofluorescence 
assay. 
Results: The age of khat chewers ranged from 30-60 years with mean age 40.4±7.6 years. Non-
khat chewers age ranged from 30-57 years with mean age 39.9±6.2 years. The majority of khat 
chewers and non-chewers were in age groups 30-39 and 40-49 years old. There is no association 
between khat chewing and ANA or ASMA serum positivity (χ2 = 0.33, P = 0.39 and χ2 = 1.5, P 
= 0.16; respectively). However, ANA and ASMA positivity were significantly increased with 
age of the participants (χ2 = 7.79, P = 0.044 and χ2 = 10.6, P = 0.011, respectively).  
Conclusion: khat chewing has no association with ANA and ASMA positivity. Nevertheless, 
ANA and ASMA positivity has an association with aging.  
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Introduction 
Autoimmune hepatitis (AIH) is a chronic inflammatory liver disease in which the immune 
system attacks liver cells.
1
 AIH is a relatively uncommon disease. It can occur any age but it is 
most common in young females. It is characterized by elevated levels of serum transaminases, 
seropositivity for autoantibodies, a histological picture of interface hepatitis and well-response to 
immunosuppression therapy.
2-5
 According to the pattern of autoantibodies in patient’s serum, 
AIH is subdivided into two types. Type 1 AIH is the most common form of AIH, (80% of AIH 
cases). It is commonly termed as a classic AIH. Type 1 AIH is mainly characterized by 
circulating antinuclear antibodies (ANA), anti-smooth muscle antibodies (SMA), atypical 
perinuclear antineutrophilic cytoplasmic antibodies (pANCA), and soluble liver antigen/liver 
pancreas (SLA/LP).
6-9
 Type 2 AIH is a rare disorder and is mainly pediatric; average age is 
around 10 years. AIH type 2 is characterized by presence of liver/kidney microsomal antibodies 
type 1, 2 or 3 (LKM-1, 2 and 3) and liver cytosol type 1 (anti-LC-1). 
6,9,10
 
The etiology of AIH remains unknown but is postulated to be related to an autoimmune process 
triggered by either genetic predisposition or environmental agents. AIH is strongly associated 
with human leukocyte antigens (HLA-DR3 and HLA-DR4, HLA-DR6).
11-14
 Environmental 
factors are thought to be the triggering factors for the development of AIH in genetically 
  
 
susceptible individuals. These environmental factors could be viruses, drugs, chemicals or 
certain herbs.
15-17
 
Khat (Catha edulis) is an herb its leaves have been chewed for centuries by people who live in 
the Eastern part of Africa and Yemen. The khat leaves chewed daily by a high proportion of the 
adult population in Yemen for the pleasant mild stimulant effect.
18
 Khat has recently been 
recognized as a triggering agent for a severe form of AIH in young males in Yemen and 
Somalia.
19-23
 Our study aimed to measure serum ANA and ASMA as early markers for AIH 
type1 in Yemeni healthy people who chew khat.  
Subjects and methods 
Our study was a cross-sectional study which was conducted for four months from March to June, 
2014. It was carried out in Sana'a city, the capital of Yemen. One hundred individuals were 
enrolled in the study divided into two groups. First group involved 50 individuals who daily 
chew khat for at least five years. Second group include 50 persons who never chewed khat. 
According to gender, the two previous groups were subdivided into 25 males and 25 females. 
Participants were selected randomly from khat or social sessions. Study was approved by Faculty 
of Medicine and Health Sciences, University of Science and Technology. Written consent was 
obtained from each participant. 
Inclusion criteria 
Any apparently healthy individual who was equal or over 30 years, did not complain any signs 
and symptoms and did not take any medications.  
Exclusion criteria 
Carriers of hepatitis viruses, pregnant women or females who ingested oral contraceptive pills 
were excluded from the two study groups.  
Data from each individual were collected using predesigned questionnaire. Three ml of venous 
blood was withdrawn from each person into a plain tube. The sample was allowed to clot at room 
temperature and was centrifuged at 3500 rpm for five minutes, then serum was separated from 
each sample into Eppendorf tubes and stored at -20 °C till tested. Serum ANA and ASMA were 
measured using indirect immunofluorescence assay on HEp2 cells according to manufacturer 
instructions (Innova, San Diego, USA). The nuclear staining patterns of ANA test were detected 
on liver and gastric cells. Nuclear staining patterns observed on theses tissues include: 
homogenous, centromere, speckled, peripheral and nucleolar. Sera were considered as positive 
for ANA when titers were >1/80 and positive for ASMA when titers were >1/40. 
Data analysis: 
Statistical data analysis was done using SPSS (version 15). Data were presented as numbers and 
percentages. Significant association was measured using χ2 and P value tests. P-value less than 
0.05 was considered statistical significant. 
Results 
This study was conducted on 50 khat chewers and 50 non-khat chewers. The age of the khat 
chewers ranged from 30 years to 60 years with mean age 40.4±7.6 years old. The age of non-
khat chewers ranged from 30 years to 57 years with mean age 39.9±6.2 years old.  
The prevalence of serum ANA among the study groups was 14%. ANA test was positive in 
8(16%) of khat chewers whereas it was positive in 6(12%) of non khat chewers. The difference 
was statistical non-significant (χ2 = 0.33, P = 0.39). ASMA test was positive in 21 % of the study 
population. It was positive in 13(26%) of khat chewers whereas it was positive in 8(16%) in non 
khat chewers (χ2 = 1.5, P = 0.16), table 1. 
  
 
ANA test was positive in 4(8.3%) individuals at age group 30-39 years old, in 5(12.8%) 
individuals at age 40-49 years old, and in 5(33.3%) at age 50-60 years old. This difference was 
statistically significant (χ2 = 7.79, P = 0.044), table 2. 
ASMA test was positive in 6(12.5%) individuals at age group 30-39 years old, in 8(20.5%) 
individuals at age 40-49 years old, and in 7(54%) at age 50-60 years old. The association 
between ASMA and age was statistical significant (χ2 = 10.6, P value = 0.011), table 3. 
Eight (16%) males had ANA positive results while 6(12%) females had ANA positive tests. The 
difference in ANA results between both males and females was non-statistically significant (χ2 = 
0.33 and P = 0.4), table 4. Seven (14%) males had ASMA positive results whereas 14(28%) 
females had ASMA positive tests. The difference in ASMA results between both males and 
females was non-statistically significant (χ2 = 3 and P = 0.07), table 4. 
Twenty eight (56%) of khat chewers were washing khat before chewing while 8(16%) did not 
wash khat or rarely washing khat (14, 28%). Although the majority of ANA test positive did not 
or rarely wash khat before chewing than those who washed khat, there is no statistical significant 
association (χ2 = 3.76 and P = 1.5). Furthermore, no association was found between khat 
washing and ASMA positivity (χ2 = 0.9 and P = 0.65), table 5.  
ANA test was positive in 5(5%) smokers and ASMA test was positive in 6(6%) and 1(1%) who 
smoked sometimes. The association between ANA and ASMA positivity with smoking was 
statistical non-significant (χ2 = 0.89, P = 0.53; χ2 = 0.3, P = 0.87, respectively), table 6. 
Discussion 
AIH type 1 occurs primarily in adults with a female predominance. Pathogenesis of AIH type 1 
is unknown, though both genetic and environmental factors are likely to predispose to the 
disease. Circulating ANA and ASMA are key to the diagnosis of AIH type 1.
24
 Khat chewing is 
proposed to cause AIH. 
25
 Hence our study aimed to measure serum ANA and ASMA among 
khat chewers and non-khat chewers as early markers for liver damage by khat chewing.  
This study revealed that chewing khat had no association with increased serum level of ANA or 
ASMA. Although Riyaz et al, 2014,
25
 reported khat to be a possible cause of AIH, our findings 
suggest that khat chewing may have no direct role in the induction of ANA and ASMA 
production and imply Khat interaction with other factors such as genetic susceptibility and khat 
abuse in the pathogenesis of AIH. Another explanation is that Khat risks on hepatocytes may be 
due to other mechanisms such as hepatotoxicity or increase the rate of hepatocytes apoptosis 
rather than autoantibody production. 
26-29
 
Our study showed that the positivity of ANA and ASMA tests were increasing by increase age. 
This result is supported by studies which reported serum ANA prevalence in the general 
population to be highest in elders.
30-32
 Nevertheless, other studies found no association between 
serum ANA with age.
33-34
 
Equal males and females were enrolled in this study. No statistical differences were found 
between the ANA and ASMA results in both men and women. This finding is in agreement with 
other study which reported no association between ANAs and gender.
31,33,35,36
 In contrast, other 
studies reported presence of ANA and/or ASMA to be more predominant in females than in 
males. 
30, 34, 35, 37
 
Current study demonstrates that smoking had no association with ANA and ASMA positivity. 
Similar results are reported by other studies.
30,33, 36,38,39
 On the other hand, this finding is in 
disagreement with Karabulut et al, 2011, who reported association between ANAs positivity and 
smoking.
40
 
  
 
Many khat farmers use pesticides for better khat cultivation which may have harmful effects on 
liver cells. Serum positivity of ANA was more frequent among participants who did not wash 
khat; however, the difference was not statistical significant which may be attributed to small 
number of the studied sample.  
Conclusion 
Khat chewing has no association with ANA and ASMA positivity. Nevertheless, ANA and 
ASMA positivity has an association with aging. Therefore, adults over 30 years old should be 
screened for ANA and ASMA positivity because such individuals are at risk for development of 
autoimmune diseases. 
Limitations of the study 
Obstacles which we encountered during the study were difficulty to determine type and amount 
of khat as well as time for how long chewing.  
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Khat 
chewers 
Non-khat 
chewers 
χ2 OR  95% CI P 
ANA test results     
Positive 8 (16%) 6 (12%) 
0.33 1.4 0.447-4.367 0.39 
Negative 42 (84%) 44 (88%) 
ASMA test results     
Positive 13 (26%) 8 (16%) 
1.5 1.84 0.67-4.04 0.16 
Negative 37 (76%) 42 (82%) 
 
Table 2: ANA test results in different age groups 
 
ANA test results 
χ2 P Positive Negative 
N % N % 
30-39 years (n= 48) 4  8.3 44 91.7 
7.79 0.044 40-49 years (n= 39) 5 12.8 34 87.2 
50-59 years (n= 13) 5 38.5 8 61.5 
Total 14 14 86 86   
Table 1: ANA and ASMA test resultsfor khat chewers and non-khat chewers 
 
  
 
 
Table 3: ASMA test results in different age groups 
 
ASMA test results 
χ2 P Positive Negative 
N % N % 
30-39 years (n= 48) 6 12.5 42 87.5 
10.6 0.011 40-49 years (n= 39) 8 20.5 31 79.5 
50-60 years (n= 13) 7 54 6 46 
Total 21 21 79 79   
 
 
Table 4: ANA and ASMA positivity among both males and females 
 
Males  Females 
χ2 OR 95% CI P 
No. % No. % 
ANA test 
 
Positive 8  16 % 6  12 % 
0.33 1.4 
0.447-
4.367 
0.4 
Negative 42 84 % 44 84% 
ASMA test 
 
Positive 7  14 % 14  28 % 
3 1.8 
0.687-
4.94 
0.07 
Negative 43 86 % 36 72% 
 
 
 
 
  
 
Table 5: Association of ANA and ASMA with khat washing 
 
ANA positivity 
χ2 P Positive Negative 
No. % No. % 
Yes 2 4 26 52 
3.76 1.5 No 2 4 6 12 
Rarely 4 8 10 20 
 
ASMA positivity 
  Positive Negative 
No. % No. % 
Yes 6 12 22 44 
0.9 0.65 No 3 6 5 10 
Rarely 4 8 10 20 
Table 6: ANA and ASMA test results with smoking 
 
ANA test results 
χ2 P Positive Negative 
No. % No. % 
Yes 5 5 23 23 
0.89 0.53 No 9 9 60 60 
sometimes 0 0 3 3 
 
ASMA test results 
  Positive Negative 
No. % No. % 
Yes 6 6 22 22 
0.3 0.87 No 14 14 55 55 
sometimes 1 1 2 2 
 
